Adverum Biotechnologies (NASDAQ:ADVM) Upgraded at StockNews.com
StockNews.com upgraded shares of Adverum Biotechnologies (NASDAQ:ADVM – Get Rating) from a sell rating to a hold rating in a research report report published on Monday. Separately, LADENBURG THALM/SH SH started coverage on Adverum Biotechnologies in a report on Tuesday, March 7th. They set a buy rating and a $2.00 target price on the stock. […]